| Literature DB >> 31981079 |
C Guillén-Ponce1, E Lastra2, I Lorenzo-Lorenzo3, T Martín Gómez4, R Morales Chamorro5, A B Sánchez-Heras6, R Serrano7, M C Soriano Rodríguez8, J L Soto9, L Robles10.
Abstract
In the last 2 decades, clinical genetics on hereditary colorectal syndromes has shifted from just a molecular characterization of the different syndromes to the estimation of the individual risk of cancer and appropriate risk reduction strategies. In the last years, new specific therapies for some subgroups of patients have emerged as very effective alternatives. At the same time, germline multigene panel testing by next-generation sequencing (NGS) technology has become the new gold standard for molecular genetics.Entities:
Keywords: Adenomatous polyposis; Colon cancer; Hereditary colorectal cancer; Lynch syndrome
Year: 2020 PMID: 31981079 DOI: 10.1007/s12094-019-02272-y
Source DB: PubMed Journal: Clin Transl Oncol ISSN: 1699-048X Impact factor: 3.405